HCRT and atherosclerosis: These phospholipid oxidation products are present in sites of chronic inflammation, in apoptotic cell membranes, and in oxidized LDL [26], suggesting a potential pathophysiologic role of Ox-PAPC-dependent LTR4 activation in atherosclerosis.